Fig. 4From: Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301Kaplan-Meier estimates of overall survival for all patientsBack to article page